Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
25
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Borgman Anne Elizabeth | Director | 6 | $0 | $0 | 2026-07-07 |
| Zung Jonathan B. | CDO | 11 | $0 | $0 | 2026-07-07 |
| Duvall Diantha | CFO | 11 | $0 | $0 | 2026-07-07 |
| Hohneker John | Director | 7 | $0 | $0 | 2026-07-07 |
| Rubin Marc | Director | 24 | $24.5K | $19.4K | 2026-07-07 |
| Dentzer James E | President & CEO | 28 | $0 | $92.4K | 2026-07-07 |
| KAITIN KENNETH I | Director | 29 | $5.5K | $41.9K | 2026-07-07 |
| GREENACRE MARTYN D | Director | 39 | $0 | $874.1K | 2026-07-07 |
| Hamdy Ahmed MD | CMO | 7 | $0 | $0 | 2026-03-20 |
| Martell Robert | Head of Research & Development | 15 | $0 | $5.9K | 2023-01-20 |
| Kunkel Lori Anne | Director | 8 | $0 | $15.5K | 2022-01-31 |
| Steinkrauss William | Chief Financial Officer | 4 | $0 | $0 | 2022-01-29 |
| Tuck David | Chief Medical Officer | 4 | $0 | $0 | 2018-05-15 |
| Fattaey Ali Ph.D. | President & COO | 15 | $161.2K | $0 | 2018-05-15 |
| MCNAB JAMES R | Director | 37 | $200.0K | $3.17M | 2017-05-05 |
| Pienta Kenneth | Director | 7 | $102.7K | $0 | 2017-02-28 |
| Mohindru Mani | Sr. VP, Corp. Strategy & IR | 3 | $0 | $0 | 2017-02-14 |
| Dr. Reddy's Holdings Ltd | 10% Owner | 1 | $24.50M | $0 | 2016-09-07 |
| PASSERI DANIEL R | Director | 76 | $75.8K | $3.40M | 2016-01-19 |
| Viner Jaye | Chief Medical Officer | 8 | $0 | $0 | 2015-05-27 |
| GRAY MICHAEL | COO and CFO | 27 | $28.6K | $327.0K | 2015-05-27 |
| TOBIN JAMES R | Director | 11 | $0 | $0 | 2015-01-26 |
| NOEL MARK | VP, Tech Management | 19 | $0 | $837.9K | 2013-05-02 |
| Voi Maurizio | Chief Medical Officer | 4 | $0 | $0 | 2013-01-17 |
| BAYH SUSAN B | Director | 2 | $0 | $0 | 2013-01-17 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Dentzer James E | President & CEO | A Award deriv | 2026-07-07 | 2026-07-09 | 110,090 | $5.29 | $582.4K | 110,090 | SEC↗ |
| Zung Jonathan B. | CDO | A Award deriv | 2026-07-07 | 2026-07-09 | 48,285 | $5.29 | $255.4K | 48,285 | SEC↗ |
| Duvall Diantha | CFO | A Award deriv | 2026-07-07 | 2026-07-09 | 48,285 | $5.29 | $255.4K | 48,285 | SEC↗ |
| Borgman Anne Elizabeth | Director | A Award deriv | 2026-07-07 | 2026-07-09 | 6,800 | $5.29 | $36.0K | 6,800 | SEC↗ |
| GREENACRE MARTYN D | Director | A Award deriv | 2026-07-07 | 2026-07-09 | 6,800 | $5.29 | $36.0K | 6,800 | SEC↗ |
| Hohneker John | Director | A Award deriv | 2026-07-07 | 2026-07-09 | 6,800 | $5.29 | $36.0K | 6,800 | SEC↗ |
| KAITIN KENNETH I | Director | A Award deriv | 2026-07-07 | 2026-07-09 | 6,800 | $5.29 | $36.0K | 6,800 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2026-07-07 | 2026-07-09 | 6,800 | $5.29 | $36.0K | 6,800 | SEC↗ |
| KAITIN KENNETH I | Director | P Buy | 2026-03-31 | 2026-04-01 | 10,000 | $0.55 | $5.5K | 11,407 | SEC↗ |
| Rubin Marc | Director | C Conversion deriv | 2026-03-20 | 2026-03-23 | 20 | — | $0 | 0 | SEC↗ |
| Dentzer James E | President & CEO | C Conversion deriv | 2026-03-20 | 2026-03-23 | 100 | — | $0 | 0 | SEC↗ |
| Duvall Diantha | CFO | C Conversion deriv | 2026-03-20 | 2026-03-23 | 50 | — | $0 | 0 | SEC↗ |
| Hamdy Ahmed MD | CMO | C Conversion deriv | 2026-03-20 | 2026-03-23 | 50 | — | $0 | 0 | SEC↗ |
| Zung Jonathan B. | CDO | C Conversion deriv | 2026-03-20 | 2026-03-23 | 50 | — | $0 | 0 | SEC↗ |
| Rubin Marc | Director | C Conversion | 2026-03-20 | 2026-03-23 | 26,667 | — | $0 | 28,108 | SEC↗ |
| Dentzer James E | President & CEO | C Conversion | 2026-03-20 | 2026-03-23 | 133,333 | — | $0 | 148,730 | SEC↗ |
| Duvall Diantha | CFO | C Conversion | 2026-03-20 | 2026-03-23 | 66,666 | — | $0 | 77,707 | SEC↗ |
| Hamdy Ahmed MD | CMO | C Conversion | 2026-03-20 | 2026-03-23 | 66,667 | — | $0 | 66,667 | SEC↗ |
| Zung Jonathan B. | CDO | C Conversion | 2026-03-20 | 2026-03-23 | 66,667 | — | $0 | 66,667 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2026-03-17 | 2026-03-18 | 26,667 | — | $0 | 26,667 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2026-03-17 | 2026-03-18 | 20 | — | $0 | 20 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2026-03-17 | 2026-03-18 | 26,667 | — | $0 | 26,667 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2026-03-17 | 2026-03-18 | 26,667 | — | $0 | 26,667 | SEC↗ |
| Dentzer James E | President & CEO | A Award deriv | 2026-03-17 | 2026-03-18 | 133,333 | — | $0 | 133,333 | SEC↗ |
| Dentzer James E | President & CEO | A Award deriv | 2026-03-17 | 2026-03-18 | 133,333 | — | $0 | 133,333 | SEC↗ |
| Dentzer James E | President & CEO | A Award deriv | 2026-03-17 | 2026-03-18 | 133,333 | — | $0 | 133,333 | SEC↗ |
| Dentzer James E | President & CEO | A Award deriv | 2026-03-17 | 2026-03-18 | 100 | — | $0 | 100 | SEC↗ |
| Duvall Diantha | CFO | A Award deriv | 2026-03-17 | 2026-03-18 | 50 | — | $0 | 50 | SEC↗ |
| Duvall Diantha | CFO | A Award deriv | 2026-03-17 | 2026-03-18 | 66,666 | — | $0 | 66,666 | SEC↗ |
| Duvall Diantha | CFO | A Award deriv | 2026-03-17 | 2026-03-18 | 66,666 | — | $0 | 66,666 | SEC↗ |
| Duvall Diantha | CFO | A Award deriv | 2026-03-17 | 2026-03-18 | 66,666 | — | $0 | 66,666 | SEC↗ |
| Hamdy Ahmed MD | CMO | A Award deriv | 2026-03-17 | 2026-03-18 | 50 | — | $0 | 50 | SEC↗ |
| Hamdy Ahmed MD | CMO | A Award deriv | 2026-03-17 | 2026-03-18 | 66,667 | — | $0 | 66,667 | SEC↗ |
| Hamdy Ahmed MD | CMO | A Award deriv | 2026-03-17 | 2026-03-18 | 66,667 | — | $0 | 66,667 | SEC↗ |
| Hamdy Ahmed MD | CMO | A Award deriv | 2026-03-17 | 2026-03-18 | 66,667 | — | $0 | 66,667 | SEC↗ |
| Zung Jonathan B. | CDO | A Award deriv | 2026-03-17 | 2026-03-18 | 66,667 | — | $0 | 66,667 | SEC↗ |
| Zung Jonathan B. | CDO | A Award deriv | 2026-03-17 | 2026-03-18 | 66,667 | — | $0 | 66,667 | SEC↗ |
| Zung Jonathan B. | CDO | A Award deriv | 2026-03-17 | 2026-03-18 | 66,667 | — | $0 | 66,667 | SEC↗ |
| Zung Jonathan B. | CDO | A Award deriv | 2026-03-17 | 2026-03-18 | 50 | — | $0 | 50 | SEC↗ |
| KAITIN KENNETH I | Director | A Award deriv | 2025-05-20 | 2025-05-22 | 14,400 | $3.13 | $45.1K | 14,400 | SEC↗ |
| Zung Jonathan B. | CDO | A Award deriv | 2025-05-20 | 2025-05-22 | 135,000 | $3.13 | $422.6K | 135,000 | SEC↗ |
| Borgman Anne Elizabeth | Director | A Award deriv | 2025-05-20 | 2025-05-22 | 14,400 | $3.13 | $45.1K | 14,400 | SEC↗ |
| Duvall Diantha | CFO | A Award deriv | 2025-05-20 | 2025-05-22 | 135,000 | $3.13 | $422.6K | 135,000 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2025-05-20 | 2025-05-22 | 14,400 | $3.13 | $45.1K | 14,400 | SEC↗ |
| GREENACRE MARTYN D | Director | A Award deriv | 2025-05-20 | 2025-05-22 | 14,400 | $3.13 | $45.1K | 14,400 | SEC↗ |
| Hohneker John | Director | A Award deriv | 2025-05-20 | 2025-05-22 | 14,400 | $3.13 | $45.1K | 14,400 | SEC↗ |
| Dentzer James E | President & CEO | A Award deriv | 2025-05-20 | 2025-05-22 | 360,000 | $3.13 | $1.13M | 360,000 | SEC↗ |
| Hamdy Ahmed MD | CMO | A Award deriv | 2025-05-01 | 2025-05-05 | 200,000 | $2.48 | $496.0K | 200,000 | SEC↗ |
| GREENACRE MARTYN D | Director | A Award deriv | 2025-01-28 | 2025-01-30 | 1,600 | $3.13 | $5.0K | 1,600 | SEC↗ |
| Hohneker John | Director | A Award deriv | 2025-01-28 | 2025-01-30 | 1,600 | $3.13 | $5.0K | 1,600 | SEC↗ |
| Borgman Anne Elizabeth | Director | A Award deriv | 2025-01-28 | 2025-01-30 | 1,600 | $3.13 | $5.0K | 1,600 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2025-01-28 | 2025-01-30 | 1,600 | $3.13 | $5.0K | 1,600 | SEC↗ |
| KAITIN KENNETH I | Director | A Award deriv | 2025-01-28 | 2025-01-30 | 1,600 | $3.13 | $5.0K | 1,600 | SEC↗ |
| Zung Jonathan B. | CDO | A Award deriv | 2025-01-28 | 2025-01-30 | 15,000 | $3.13 | $47.0K | 15,000 | SEC↗ |
| Dentzer James E | President & CEO | A Award deriv | 2025-01-28 | 2025-01-30 | 40,000 | $3.13 | $125.2K | 40,000 | SEC↗ |
| Duvall Diantha | CFO | A Award deriv | 2025-01-28 | 2025-01-30 | 15,000 | $3.13 | $47.0K | 15,000 | SEC↗ |
| GREENACRE MARTYN D | Director | A Award deriv | 2024-05-21 | 2024-05-23 | 4,250 | $11.62 | $49.4K | 4,250 | SEC↗ |
| Hohneker John | Director | A Award deriv | 2024-05-21 | 2024-05-23 | 4,250 | $11.62 | $49.4K | 4,250 | SEC↗ |
| Borgman Anne Elizabeth | Director | A Award deriv | 2024-05-21 | 2024-05-23 | 4,250 | $11.62 | $49.4K | 4,250 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2024-05-21 | 2024-05-23 | 4,250 | $11.62 | $49.4K | 4,250 | SEC↗ |
| KAITIN KENNETH I | Director | A Award deriv | 2024-05-21 | 2024-05-23 | 4,250 | $11.62 | $49.4K | 4,250 | SEC↗ |
| Zung Jonathan B. | CDO | A Award deriv | 2024-05-21 | 2024-05-23 | 40,700 | $11.62 | $472.9K | 40,700 | SEC↗ |
| Dentzer James E | President & CEO | A Award deriv | 2024-05-21 | 2024-05-23 | 100,000 | $11.62 | $1.16M | 100,000 | SEC↗ |
| Duvall Diantha | CFO | A Award deriv | 2024-05-21 | 2024-05-23 | 39,000 | $11.62 | $453.2K | 39,000 | SEC↗ |
| Zung Jonathan B. | CDO | A Award deriv | 2023-05-01 | 2023-05-03 | 500,000 | $0.83 | $415.0K | 500,000 | SEC↗ |
| Borgman Anne Elizabeth | Director | A Award deriv | 2023-01-23 | 2023-01-24 | 85,000 | — | $0 | 85,000 | SEC↗ |
| GREENACRE MARTYN D | Director | A Award deriv | 2023-01-23 | 2023-01-24 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2023-01-23 | 2023-01-24 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Hohneker John | Director | A Award deriv | 2023-01-23 | 2023-01-24 | 85,000 | — | $0 | 85,000 | SEC↗ |
| KAITIN KENNETH I | Director | A Award deriv | 2023-01-23 | 2023-01-24 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Dentzer James E | President & CEO | A Award deriv | 2023-01-20 | 2023-01-24 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| Martell Robert | Head of Research & Developme | A Award deriv | 2023-01-20 | 2023-01-24 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Duvall Diantha | CFO | A Award deriv | 2023-01-20 | 2023-01-24 | 500,000 | — | $0 | 500,000 | SEC↗ |
| Borgman Anne Elizabeth | Director | A Award deriv | 2022-10-12 | 2022-10-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GREENACRE MARTYN D | Director | A Award deriv | 2022-01-31 | 2022-01-31 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Hohneker John | Director | A Award deriv | 2022-01-31 | 2022-01-31 | 85,000 | — | $0 | 85,000 | SEC↗ |
| KAITIN KENNETH I | Director | A Award deriv | 2022-01-31 | 2022-01-31 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Kunkel Lori Anne | Director | A Award deriv | 2022-01-31 | 2022-01-31 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2022-01-31 | 2022-01-31 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Dentzer James E | President & CEO | S Sale | 2022-01-31 | 2022-01-31 | 3,094 | $3.07 | $9.5K | 64,877 | SEC↗ |
| Dentzer James E | President & CEO | A Award deriv | 2022-01-29 | 2022-01-31 | 825,000 | — | $0 | 825,000 | SEC↗ |
| Martell Robert | Head of Research & Developme | A Award deriv | 2022-01-29 | 2022-01-31 | 252,000 | — | $0 | 252,000 | SEC↗ |
| Steinkrauss William | Chief Financial Officer | A Award deriv | 2022-01-29 | 2022-01-31 | 360,000 | — | $0 | 360,000 | SEC↗ |
| Dentzer James E | President & CEO | S Sale | 2022-01-27 | 2022-01-31 | 2,406 | $3.18 | $7.7K | 67,971 | SEC↗ |
| Hohneker John | Director | A Award deriv | 2021-12-02 | 2021-12-06 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KAITIN KENNETH I | Director | A Award deriv | 2021-01-28 | 2021-01-29 | 33,000 | — | $0 | 33,000 | SEC↗ |
| Kunkel Lori Anne | Director | A Award deriv | 2021-01-28 | 2021-01-29 | 33,000 | — | $0 | 33,000 | SEC↗ |
| Dentzer James E | President & CEO | A Award deriv | 2021-01-28 | 2021-01-29 | 330,000 | — | $0 | 330,000 | SEC↗ |
| Steinkrauss William | Chief Financial Officer | A Award deriv | 2021-01-28 | 2021-01-29 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Martell Robert | Head of Research & Developme | A Award deriv | 2021-01-28 | 2021-01-29 | 126,000 | — | $0 | 126,000 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2021-01-28 | 2021-01-29 | 33,000 | — | $0 | 33,000 | SEC↗ |
| GREENACRE MARTYN D | Director | A Award deriv | 2021-01-28 | 2021-01-29 | 33,000 | — | $0 | 33,000 | SEC↗ |
| Dentzer James E | President & CEO | S Sale | 2021-01-26 | 2021-01-26 | 3,094 | $10.59 | $32.8K | 67,268 | SEC↗ |
| Dentzer James E | President & CEO | S Sale | 2021-01-25 | 2021-01-26 | 2,283 | $10.96 | $25.0K | 70,362 | SEC↗ |
| Dentzer James E | President & CEO | A Award deriv | 2020-03-02 | 2020-03-04 | 750,000 | — | $0 | 750,000 | SEC↗ |
| Martell Robert | Head of Research & Developme | A Award deriv | 2020-03-02 | 2020-03-04 | 385,000 | — | $0 | 385,000 | SEC↗ |
| Steinkrauss William | Chief Financial Officer | A Award deriv | 2020-03-02 | 2020-03-04 | 385,000 | — | $0 | 385,000 | SEC↗ |
| GREENACRE MARTYN D | Director | A Award deriv | 2020-03-02 | 2020-03-04 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2020-03-02 | 2020-03-04 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Kunkel Lori Anne | Director | A Award deriv | 2020-03-02 | 2020-03-04 | 180,000 | — | $0 | 180,000 | SEC↗ |
| KAITIN KENNETH I | Director | A Award deriv | 2020-03-02 | 2020-03-04 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Dentzer James E | President & CEO | S Sale | 2020-01-24 | 2020-01-24 | 3,094 | $1.64 | $5.1K | 42,158 | SEC↗ |
| Dentzer James E | President & CEO | S Sale | 2020-01-23 | 2020-01-24 | 3,658 | $1.69 | $6.2K | 45,252 | SEC↗ |
| Steinkrauss William | Chief Financial Officer | A Award deriv | 2019-09-10 | 2019-09-12 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Martell Robert | Head of Research & Developme | A Award deriv | 2019-05-23 | 2019-05-28 | 386,996 | — | $0 | 386,996 | SEC↗ |
| Dentzer James E | President & CEO | A Award deriv | 2019-05-23 | 2019-05-28 | 1,115,871 | — | $0 | 1,115,871 | SEC↗ |
| Dentzer James E | President & CEO | S Sale | 2019-01-24 | 2019-01-25 | 3,094 | $1.16 | $3.6K | 41,639 | SEC↗ |
| KAITIN KENNETH I | Director | S Sale | 2019-01-23 | 2019-01-25 | 14,800 | $1.05 | $15.5K | 28,121 | SEC↗ |
| Kunkel Lori Anne | Director | S Sale | 2019-01-23 | 2019-01-25 | 14,800 | $1.05 | $15.5K | 22,200 | SEC↗ |
| Rubin Marc | Director | S Sale | 2019-01-23 | 2019-01-25 | 18,500 | $1.05 | $19.4K | 28,819 | SEC↗ |
| GREENACRE MARTYN D | Director | S Sale | 2019-01-23 | 2019-01-25 | 18,500 | $1.05 | $19.4K | 26,089 | SEC↗ |
| Martell Robert | Head of Research & Developme | S Sale | 2019-01-23 | 2019-01-25 | 5,500 | $1.07 | $5.9K | 23,027 | SEC↗ |
| Martell Robert | Head of Research & Developme | F Tax w/h | 2019-01-23 | 2019-01-25 | 8,473 | $1.07 | $9.1K | 28,527 | SEC↗ |
| Dentzer James E | President & CEO | S Sale | 2019-01-23 | 2019-01-25 | 2,397 | $1.09 | $2.6K | 44,733 | SEC↗ |
| Kunkel Lori Anne | Director | A Award deriv | 2019-01-21 | 2019-01-23 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2019-01-21 | 2019-01-23 | 180,000 | — | $0 | 180,000 | SEC↗ |
| KAITIN KENNETH I | Director | A Award deriv | 2019-01-21 | 2019-01-23 | 180,000 | — | $0 | 180,000 | SEC↗ |
| GREENACRE MARTYN D | Director | A Award deriv | 2019-01-21 | 2019-01-23 | 180,000 | — | $0 | 180,000 | SEC↗ |
| Dentzer James E | President & CEO | A Award deriv | 2018-09-26 | 2018-09-27 | 750,000 | — | $0 | 750,000 | SEC↗ |
| Martell Robert | Head of Research & Developme | A Award deriv | 2018-06-01 | 2018-06-05 | 303,000 | — | $0 | 303,000 | SEC↗ |
| Fattaey Ali Ph.D. | President & CEO | A Award deriv | 2018-05-15 | 2018-05-17 | 825,000 | — | $0 | 825,000 | SEC↗ |
| Dentzer James E | COO & CFO | A Award deriv | 2018-05-15 | 2018-05-17 | 825,000 | — | $0 | 825,000 | SEC↗ |
| Tuck David | Chief Medical Officer | A Award deriv | 2018-05-15 | 2018-05-17 | 535,000 | — | $0 | 535,000 | SEC↗ |
| Fattaey Ali Ph.D. | President & CEO | A Award | 2018-01-22 | 2018-01-24 | 206,250 | — | $0 | 322,140 | SEC↗ |
| Dentzer James E | Chief Financial Officer | A Award | 2018-01-22 | 2018-01-24 | 206,250 | — | $0 | 212,011 | SEC↗ |
| Tuck David | Chief Medical Officer | A Award | 2018-01-22 | 2018-01-24 | 133,750 | — | $0 | 169,424 | SEC↗ |
| GREENACRE MARTYN D | Director | A Award | 2018-01-22 | 2018-01-24 | 185,000 | — | $0 | 222,945 | SEC↗ |
| KAITIN KENNETH I | Director | A Award | 2018-01-22 | 2018-01-24 | 185,000 | — | $0 | 214,607 | SEC↗ |
| Rubin Marc | Director | A Award | 2018-01-22 | 2018-01-24 | 185,000 | — | $0 | 236,596 | SEC↗ |
| Kunkel Lori Anne | Director | A Award | 2018-01-22 | 2018-01-24 | 185,000 | — | $0 | 185,000 | SEC↗ |
| Martell Robert | Director | A Award | 2018-01-22 | 2018-01-24 | 185,000 | — | $0 | 185,000 | SEC↗ |
| Rubin Marc | Director | P Buy | 2017-11-16 | 2017-11-16 | 25,000 | $0.98 | $24.5K | 51,596 | SEC↗ |
| Fattaey Ali Ph.D. | President & CEO | P Buy | 2017-11-15 | 2017-11-15 | 50,000 | $1.06 | $53.0K | 115,890 | SEC↗ |
| KAITIN KENNETH I | Director | M Exercise deriv | 2017-05-31 | 2017-06-02 | 5,000 | — | $0 | 0 | SEC↗ |
| KAITIN KENNETH I | Director | M Exercise deriv | 2017-05-31 | 2017-06-02 | 10,000 | — | $0 | 0 | SEC↗ |
| GREENACRE MARTYN D | Director | M Exercise deriv | 2017-05-31 | 2017-06-02 | 10,000 | — | $0 | 0 | SEC↗ |
| GREENACRE MARTYN D | Director | M Exercise deriv | 2017-05-31 | 2017-06-02 | 5,000 | — | $0 | 0 | SEC↗ |
| KAITIN KENNETH I | Director | F Tax w/h | 2017-05-31 | 2017-06-02 | 12,193 | $1.71 | $20.9K | 29,607 | SEC↗ |
| KAITIN KENNETH I | Director | M Exercise | 2017-05-31 | 2017-06-02 | 10,000 | $1.39 | $13.9K | 36,800 | SEC↗ |
| KAITIN KENNETH I | Director | M Exercise | 2017-05-31 | 2017-06-02 | 5,000 | $1.39 | $6.9K | 41,800 | SEC↗ |
| GREENACRE MARTYN D | Director | F Tax w/h | 2017-05-31 | 2017-06-02 | 12,193 | $1.71 | $20.9K | 37,945 | SEC↗ |
| GREENACRE MARTYN D | Director | M Exercise | 2017-05-31 | 2017-06-02 | 5,000 | $1.39 | $6.9K | 50,138 | SEC↗ |
| GREENACRE MARTYN D | Director | M Exercise | 2017-05-31 | 2017-06-02 | 10,000 | $1.39 | $13.9K | 45,138 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-05-05 | 2017-05-05 | 16,176 | $1.90 | $30.7K | 50,000 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-05-05 | 2017-05-05 | 16,176 | $1.90 | $30.7K | 50,000 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-05-04 | 2017-05-05 | 30,100 | $1.97 | $59.3K | 66,176 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-05-04 | 2017-05-05 | 30,100 | $1.97 | $59.3K | 66,176 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-05-03 | 2017-05-05 | 30,000 | $2.18 | $65.4K | 96,276 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-05-03 | 2017-05-05 | 30,000 | $2.18 | $65.4K | 96,276 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-05-02 | 2017-05-02 | 35,646 | $2.31 | $82.3K | 126,276 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-05-01 | 2017-05-02 | 38,113 | $2.38 | $90.7K | 161,922 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-04-28 | 2017-05-02 | 42,949 | $2.45 | $105.2K | 200,035 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-04-27 | 2017-04-27 | 37,202 | $2.57 | $95.6K | 242,984 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-04-26 | 2017-04-27 | 32,738 | $2.65 | $86.8K | 879,688 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-04-26 | 2017-04-27 | 19,814 | $2.65 | $52.5K | 280,186 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-04-25 | 2017-04-27 | 56,940 | $2.60 | $148.0K | 912,426 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-04-24 | 2017-04-24 | 42,076 | $2.56 | $107.7K | 1,269,366 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-04-24 | 2017-04-27 | 42,076 | $2.56 | $107.7K | 969,366 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-04-21 | 2017-04-24 | 45,705 | $2.58 | $117.9K | 1,311,442 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-04-21 | 2017-04-27 | 45,705 | $2.58 | $117.9K | 1,011,442 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-04-20 | 2017-04-24 | 22,541 | $2.66 | $60.0K | 1,357,147 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2017-04-20 | 2017-04-27 | 22,541 | $2.66 | $60.0K | 1,057,147 | SEC↗ |
| Kunkel Lori Anne | Director | A Award deriv | 2017-02-28 | 2017-03-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2017-02-28 | 2017-03-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| GREENACRE MARTYN D | Director | A Award deriv | 2017-02-28 | 2017-03-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Pienta Kenneth | Director | A Award deriv | 2017-02-28 | 2017-03-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| KAITIN KENNETH I | Director | A Award deriv | 2017-02-28 | 2017-03-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| MCNAB JAMES R | Director | A Award deriv | 2017-02-28 | 2017-03-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Martell Robert | Director | A Award deriv | 2017-02-28 | 2017-03-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Fattaey Ali Ph.D. | President & CEO | A Award deriv | 2017-02-14 | 2017-02-16 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| Tuck David | Chief Medical Officer | A Award deriv | 2017-02-14 | 2017-02-16 | 534,000 | — | $0 | 534,000 | SEC↗ |
| Mohindru Mani | Chief Strategy Officer | A Award deriv | 2017-02-14 | 2017-02-16 | 424,000 | — | $0 | 424,000 | SEC↗ |
| Kunkel Lori Anne | Director | A Award deriv | 2016-11-11 | 2016-11-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Dr. Reddy's Holdings Ltd | 10% Owner | P Buy | 2016-09-07 | 2016-09-09 | 10,208,333 | $2.40 | $24.50M | 27,328,464 | SEC↗ |
| GREENACRE MARTYN D | Director | M Exercise deriv | 2016-05-27 | 2016-05-27 | 10,000 | $1.67 | $16.7K | 0 | SEC↗ |
| GREENACRE MARTYN D | Director | M Exercise deriv | 2016-05-27 | 2016-05-27 | 5,000 | $1.67 | $8.3K | 0 | SEC↗ |
| GREENACRE MARTYN D | Director | S Sale | 2016-05-27 | 2016-05-27 | 5,000 | $1.69 | $8.4K | 35,183 | SEC↗ |
| GREENACRE MARTYN D | Director | M Exercise | 2016-05-27 | 2016-05-27 | 5,000 | $1.67 | $8.3K | 40,183 | SEC↗ |
| GREENACRE MARTYN D | Director | M Exercise | 2016-05-27 | 2016-05-27 | 10,000 | $1.67 | $16.7K | 45,183 | SEC↗ |
| GREENACRE MARTYN D | Director | S Sale | 2016-05-27 | 2016-05-27 | 10,000 | $1.69 | $16.9K | 35,183 | SEC↗ |
| KAITIN KENNETH I | Director | M Exercise deriv | 2016-05-26 | 2016-05-27 | 5,000 | $1.67 | $8.3K | 0 | SEC↗ |
| KAITIN KENNETH I | Director | M Exercise deriv | 2016-05-26 | 2016-05-27 | 10,000 | $1.67 | $16.7K | 0 | SEC↗ |
| KAITIN KENNETH I | Director | S Sale | 2016-05-26 | 2016-05-27 | 10,000 | $1.76 | $17.6K | 26,800 | SEC↗ |
| KAITIN KENNETH I | Director | M Exercise | 2016-05-26 | 2016-05-27 | 5,000 | $1.67 | $8.3K | 31,800 | SEC↗ |
| KAITIN KENNETH I | Director | M Exercise | 2016-05-26 | 2016-05-27 | 10,000 | $1.67 | $16.7K | 36,800 | SEC↗ |
| KAITIN KENNETH I | Director | S Sale | 2016-05-26 | 2016-05-27 | 5,000 | $1.76 | $8.8K | 26,800 | SEC↗ |
| Dentzer James E | Chief Financial Officer | A Award deriv | 2016-03-29 | 2016-03-30 | 1,700,000 | — | $0 | 1,700,000 | SEC↗ |
| Tuck David | Chief Medical Officer | A Award deriv | 2016-03-29 | 2016-03-30 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Mohindru Mani | Chief Strategy Officer | A Award deriv | 2016-03-29 | 2016-03-30 | 200,000 | — | $0 | 200,000 | SEC↗ |
| GREENACRE MARTYN D | Director | A Award deriv | 2016-01-19 | 2016-01-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| KAITIN KENNETH I | Director | A Award deriv | 2016-01-19 | 2016-01-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Martell Robert | Director | A Award deriv | 2016-01-19 | 2016-01-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MCNAB JAMES R | Director | A Award deriv | 2016-01-19 | 2016-01-21 | 170,000 | — | $0 | 170,000 | SEC↗ |
| PASSERI DANIEL R | Director | A Award deriv | 2016-01-19 | 2016-01-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Pienta Kenneth | Director | A Award deriv | 2016-01-19 | 2016-01-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2016-01-19 | 2016-01-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Fattaey Ali Ph.D. | President & CEO | A Award deriv | 2016-01-19 | 2016-01-21 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| Mohindru Mani | Sr. VP, Corp. Strategy & IR | A Award deriv | 2016-01-19 | 2016-01-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise deriv | 2016-01-06 | 2016-01-07 | 12,900 | $1.57 | $20.3K | 0 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise | 2016-01-06 | 2016-01-07 | 12,900 | $1.57 | $20.3K | 211,798 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise deriv | 2015-12-30 | 2015-12-30 | 14,400 | $1.57 | $22.6K | 0 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise | 2015-12-30 | 2015-12-30 | 14,400 | $1.57 | $22.6K | 213,298 | SEC↗ |
| PASSERI DANIEL R | Director | S Sale | 2015-12-30 | 2015-12-30 | 14,400 | $3.01 | $43.3K | 198,898 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise deriv | 2015-12-29 | 2015-12-30 | 11,200 | $1.57 | $17.6K | 0 | SEC↗ |
| PASSERI DANIEL R | Director | S Sale | 2015-12-29 | 2015-12-30 | 11,200 | $2.91 | $32.6K | 198,898 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise | 2015-12-29 | 2015-12-30 | 11,200 | $1.57 | $17.6K | 210,098 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise deriv | 2015-12-28 | 2015-12-29 | 11,000 | $1.57 | $17.3K | 0 | SEC↗ |
| PASSERI DANIEL R | Director | S Sale | 2015-12-28 | 2015-12-29 | 11,000 | $2.84 | $31.2K | 198,898 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise | 2015-12-28 | 2015-12-29 | 11,000 | $1.57 | $17.3K | 209,898 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise deriv | 2015-12-24 | 2015-12-29 | 2,600 | $1.57 | $4.1K | 0 | SEC↗ |
| PASSERI DANIEL R | Director | S Sale | 2015-12-24 | 2015-12-29 | 2,600 | $2.90 | $7.5K | 198,898 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise | 2015-12-24 | 2015-12-29 | 2,600 | $1.57 | $4.1K | 201,498 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise deriv | 2015-12-23 | 2015-12-23 | 10,900 | $1.57 | $17.1K | 0 | SEC↗ |
| PASSERI DANIEL R | Director | S Sale | 2015-12-23 | 2015-12-23 | 10,900 | $2.90 | $31.6K | 198,898 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise | 2015-12-23 | 2015-12-23 | 10,900 | $1.57 | $17.1K | 209,798 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise deriv | 2015-12-22 | 2015-12-23 | 38,000 | $1.57 | $59.7K | 0 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise | 2015-12-22 | 2015-12-23 | 38,000 | $1.57 | $59.7K | 236,898 | SEC↗ |
| PASSERI DANIEL R | Director | S Sale | 2015-12-22 | 2015-12-23 | 38,000 | $2.75 | $104.5K | 198,898 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise deriv | 2015-12-21 | 2015-12-21 | 100,000 | $1.57 | $157.0K | 0 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise | 2015-12-21 | 2015-12-21 | 100,000 | $1.57 | $157.0K | 298,898 | SEC↗ |
| PASSERI DANIEL R | Director | S Sale | 2015-12-21 | 2015-12-21 | 100,000 | $2.87 | $287.0K | 198,898 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise deriv | 2015-12-18 | 2015-12-21 | 189,000 | $1.57 | $296.7K | 0 | SEC↗ |
| PASSERI DANIEL R | Director | S Sale | 2015-12-18 | 2015-12-21 | 189,000 | $3.05 | $576.5K | 198,898 | SEC↗ |
| PASSERI DANIEL R | Director | M Exercise | 2015-12-18 | 2015-12-21 | 189,000 | $1.57 | $296.7K | 387,898 | SEC↗ |
| Fattaey Ali Ph.D. | President & CEO | A Award deriv | 2015-05-27 | 2015-05-28 | 900,000 | — | $0 | 900,000 | SEC↗ |
| GRAY MICHAEL | CFO | A Award deriv | 2015-05-27 | 2015-05-28 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Viner Jaye | Chief Medical Officer | A Award deriv | 2015-05-27 | 2015-05-28 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Fattaey Ali Ph.D. | President & CEO | A Award deriv | 2015-01-26 | 2015-01-28 | 100,000 | — | $0 | 100,000 | SEC↗ |
| GRAY MICHAEL | CFO | A Award deriv | 2015-01-26 | 2015-01-28 | 100,000 | — | $0 | 100,000 | SEC↗ |
| GREENACRE MARTYN D | Director | A Award deriv | 2015-01-26 | 2015-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KAITIN KENNETH I | Director | A Award deriv | 2015-01-26 | 2015-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Martell Robert | Director | A Award deriv | 2015-01-26 | 2015-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MCNAB JAMES R | Director | A Award deriv | 2015-01-26 | 2015-01-28 | 85,000 | — | $0 | 85,000 | SEC↗ |
| PASSERI DANIEL R | Director | A Award deriv | 2015-01-26 | 2015-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Pienta Kenneth | Director | A Award deriv | 2015-01-26 | 2015-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TOBIN JAMES R | Director | A Award deriv | 2015-01-26 | 2015-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Viner Jaye | Chief Medical Officer | A Award deriv | 2015-01-26 | 2015-01-28 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2015-01-26 | 2015-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Fattaey Ali Ph.D. | President & CEO | P Buy | 2014-08-27 | 2014-08-28 | 62,890 | $1.60 | $100.6K | 65,890 | SEC↗ |
| Fattaey Ali Ph.D. | President & CEO | A Award deriv | 2014-06-02 | 2014-06-03 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Fattaey Ali Ph.D. | President & CEO | A Award deriv | 2014-06-02 | 2014-06-03 | 400,000 | — | $0 | 600,000 | SEC↗ |
| MCNAB JAMES R | Director | G Gift | 2014-04-02 | 2014-04-03 | 30,000 | — | $0 | 1,049,688 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | A Award deriv | 2014-02-18 | 2014-02-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | A Award deriv | 2014-02-18 | 2014-02-20 | 200,000 | — | $0 | 300,000 | SEC↗ |
| Fattaey Ali Ph.D. | President & COO | A Award deriv | 2014-02-18 | 2014-02-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Fattaey Ali Ph.D. | President & COO | A Award deriv | 2014-02-18 | 2014-02-20 | 200,000 | — | $0 | 300,000 | SEC↗ |
| Viner Jaye | Chief Medical Officer | A Award deriv | 2014-02-18 | 2014-02-20 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Viner Jaye | Chief Medical Officer | A Award deriv | 2014-02-18 | 2014-02-20 | 120,000 | — | $0 | 180,000 | SEC↗ |
| GRAY MICHAEL | CBO and CFO | A Award deriv | 2014-02-18 | 2014-02-20 | 60,000 | — | $0 | 60,000 | SEC↗ |
| GRAY MICHAEL | CBO and CFO | A Award deriv | 2014-02-18 | 2014-02-20 | 120,000 | — | $0 | 180,000 | SEC↗ |
| Viner Jaye | Chief Medical Officer | A Award deriv | 2014-02-18 | 2014-02-20 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Viner Jaye | Chief Medical Officer | A Award deriv | 2014-02-18 | 2014-02-20 | 120,000 | — | $0 | 180,000 | SEC↗ |
| Dentzer James E | Chief Financial Officer | A Award deriv | 2014-02-14 | 2017-02-16 | 650,000 | — | $0 | 650,000 | SEC↗ |
| Pienta Kenneth | Director | A Award deriv | 2014-01-27 | 2014-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GREENACRE MARTYN D | Director | A Award deriv | 2014-01-27 | 2014-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Rubin Marc | Director | A Award deriv | 2014-01-27 | 2014-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| KAITIN KENNETH I | Director | A Award deriv | 2014-01-27 | 2014-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TOBIN JAMES R | Director | A Award deriv | 2014-01-27 | 2014-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MCNAB JAMES R | Director | A Award deriv | 2014-01-27 | 2014-01-28 | 85,000 | — | $0 | 85,000 | SEC↗ |
| Martell Robert | Director | A Award deriv | 2014-01-27 | 2014-01-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Fattaey Ali Ph.D. | President & COO | P Buy | 2013-12-11 | 2013-12-12 | 3,000 | $2.52 | $7.6K | 3,000 | SEC↗ |
| GRAY MICHAEL | CFO | P Buy | 2013-11-12 | 2013-11-12 | 10,000 | $2.86 | $28.6K | 107,304 | SEC↗ |
| Pienta Kenneth | Director | P Buy | 2013-11-08 | 2013-11-08 | 20,000 | $2.95 | $59.0K | 30,000 | SEC↗ |
| Pienta Kenneth | Director | P Buy | 2013-09-16 | 2013-11-08 | 10,000 | $4.37 | $43.7K | 10,000 | SEC↗ |
| Viner Jaye | Chief Medical Officer | A Award deriv | 2013-08-27 | 2013-08-28 | 277,680 | $4.11 | $1.14M | 277,680 | SEC↗ |
| Viner Jaye | Chief Medical Officer | A Award deriv | 2013-08-27 | 2013-08-28 | 97,320 | $4.11 | $400.0K | 97,320 | SEC↗ |
| MCNAB JAMES R | Director | P Buy | 2013-08-16 | 2013-08-19 | 50,000 | $4.00 | $200.0K | 250,000 | SEC↗ |
| MCNAB JAMES R | Director | S Sale | 2013-08-16 | 2013-08-19 | 50,000 | $4.00 | $200.0K | 50,000 | SEC↗ |
| GRAY MICHAEL | CFO | G Gift | 2013-05-21 | 2013-05-23 | 6,000 | — | $0 | 97,304 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | M Exercise deriv | 2013-05-08 | 2013-05-08 | 86,852 | — | $0 | 0 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | M Exercise | 2013-05-08 | 2013-05-08 | 86,852 | $2.43 | $211.1K | 285,750 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | S Sale | 2013-05-08 | 2013-05-08 | 86,852 | $3.70 | $321.4K | 198,898 | SEC↗ |
| GRAY MICHAEL | CFO | M Exercise deriv | 2013-05-07 | 2013-05-07 | 242 | — | $0 | 0 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | M Exercise deriv | 2013-05-07 | 2013-05-08 | 51,215 | — | $0 | 0 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | M Exercise deriv | 2013-05-07 | 2013-05-08 | 136,933 | — | $0 | 86,852 | SEC↗ |
| GRAY MICHAEL | CFO | M Exercise | 2013-05-07 | 2013-05-07 | 242 | $2.43 | $588 | 103,304 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | S Sale | 2013-05-07 | 2013-05-08 | 40,000 | $3.63 | $145.2K | 198,898 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | M Exercise | 2013-05-07 | 2013-05-08 | 188,148 | $2.43 | $457.2K | 338,898 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | F Tax w/h | 2013-05-07 | 2013-05-08 | 100,000 | $3.60 | $360.0K | 238,898 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | M Exercise deriv | 2013-05-06 | 2013-05-06 | 211,452 | $2.43 | $513.8K | 0 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | M Exercise deriv | 2013-05-06 | 2013-05-06 | 51,215 | $2.43 | $124.5K | 0 | SEC↗ |
| TOBIN JAMES R | Director | M Exercise deriv | 2013-05-06 | 2013-05-07 | 62,500 | — | $0 | 0 | SEC↗ |
| GRAY MICHAEL | CFO | M Exercise deriv | 2013-05-06 | 2013-05-07 | 49,758 | — | $0 | 0 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | M Exercise deriv | 2013-05-06 | 2013-05-08 | 60,000 | — | $0 | 223,785 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | F Tax w/h | 2013-05-06 | 2013-05-06 | 135,000 | $3.63 | $490.1K | 278,417 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | S Sale | 2013-05-06 | 2013-05-06 | 60,000 | $3.66 | $219.6K | 218,417 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | M Exercise | 2013-05-06 | 2013-05-06 | 262,667 | $2.43 | $638.3K | 413,417 | SEC↗ |
| TOBIN JAMES R | Director | M Exercise | 2013-05-06 | 2013-05-07 | 62,500 | $2.43 | $151.9K | 186,751 | SEC↗ |
| TOBIN JAMES R | Director | F Tax w/h | 2013-05-06 | 2013-05-07 | 41,830 | $3.63 | $151.8K | 144,921 | SEC↗ |
| GRAY MICHAEL | CFO | M Exercise | 2013-05-06 | 2013-05-07 | 49,758 | $2.43 | $120.9K | 136,371 | SEC↗ |
| GRAY MICHAEL | CFO | F Tax w/h | 2013-05-06 | 2013-05-07 | 33,309 | $3.63 | $120.9K | 103,062 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | M Exercise | 2013-05-06 | 2013-05-08 | 60,000 | $2.43 | $145.8K | 210,750 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | S Sale | 2013-05-06 | 2013-05-08 | 60,000 | $3.66 | $219.6K | 150,750 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | M Exercise deriv | 2013-05-03 | 2013-05-06 | 65,000 | $2.43 | $157.9K | 0 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | M Exercise deriv | 2013-05-03 | 2013-05-08 | 65,000 | — | $0 | 283,785 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | S Sale | 2013-05-03 | 2013-05-06 | 65,000 | $3.73 | $242.4K | 150,750 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | M Exercise | 2013-05-03 | 2013-05-06 | 65,000 | $2.43 | $157.9K | 215,750 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | S Sale | 2013-05-03 | 2013-05-08 | 65,000 | $3.73 | $242.4K | 150,750 | SEC↗ |
| PASSERI DANIEL R | CEO and Director | M Exercise | 2013-05-03 | 2013-05-08 | 65,000 | $2.43 | $157.9K | 215,750 | SEC↗ |
| NOEL MARK | VP, Tech Management | M Exercise deriv | 2013-05-02 | 2013-05-03 | 52,258 | $2.43 | $127.0K | 0 | SEC↗ |